Former All Blacks Dan Carter and Joe Rokocoko gave drug tests which showed “anomalies” before this year’s Top 14 final, according to the French newspaper L’Equipe.

But the pair’s manager, Simon Porter, says both had therapeutic use exemptions (TUEs), giving them permission to take prescribed medicines.

Porter told the New Zealand Herald: “We have been aware of the issue for a few weeks. Our understanding and assurances we’ve had are that all the documents around TUEs were in place.”

Fly-half Carter, 34, and wing Rokocoko, 33, scored 20 points between them as their team, Racing 92, beat Toulon 29-21 in the June final in Barcelona.

L’Equipe says players were tested by France’s national anti-doping agency before the final and urine samples from the two revealed traces of corticosteroids, which are designed to reduce inflammation.

The newspaper also names a third Racing player, Pumas wing Juan Imhoff, as having anomalies in his urine test.

In the spotlight: Joe Rokocoko also had a therapeutic use exemption because of injury, says his agent

But Porter is quoted as saying the players were “relaxed” about the reports and that Carter was receiving medication for a calf injury that ultimately forced him off the field during the European Champions Cup final against Saracens in May.

Rokocoko was recovering from a knee injury.

Carter, who was Man of the Match in the Top 14 final, played 112 Tests for New Zealand and was part of the side that won the World Cup a year ago.

In his autobiography published last year, he explains that he had a cortisone shot to help get him through the 2013 tour to Europe and another injection after last year’s World Cup pool match against France, having tweaked his MCL.

Rokocoko scored 46 tries in 68 Tests between 2003 and 2010.